These include small round blue cell tumors that share some pathologic characteristics of EWS but express alternative fusions, such as BCOR-CCNB3 and CIC-DUX4, and appear to have different expected outcomes when treated with Ewing sarcoma specific therapy3,4. Here, EWSR1 is linked to Ewing sarcoma.